|Numéro de publication||US20050098431 A1|
|Type de publication||Demande|
|Numéro de demande||US 10/624,746|
|Date de publication||12 mai 2005|
|Date de dépôt||22 juil. 2003|
|Date de priorité||19 juin 1995|
|Autre référence de publication||US6413410, US6960289, US7604722, US7608175, US8075760, US8101056, US8597480, US9075004, US20020112969, US20050077176, US20050173246, US20100078324, US20100084288, US20100192369, US20120145539, US20140083850, USRE44330|
|Numéro de publication||10624746, 624746, US 2005/0098431 A1, US 2005/098431 A1, US 20050098431 A1, US 20050098431A1, US 2005098431 A1, US 2005098431A1, US-A1-20050098431, US-A1-2005098431, US2005/0098431A1, US2005/098431A1, US20050098431 A1, US20050098431A1, US2005098431 A1, US2005098431A1|
|Inventeurs||Alastair Hodges, Thomas Beck, Oddvar Johansen|
|Cessionnaire d'origine||Lifescan, Inc.|
|Exporter la citation||BiBTeX, EndNote, RefMan|
|Citations de brevets (99), Référencé par (30), Classifications (13)|
|Liens externes: USPTO, Cession USPTO, Espacenet|
This invention relates to a biosensor and more particularly to an electrochemical biosensor for determining the concentration of an analyte in a carrier. The invention is particularly useful for determining the concentration of glucose in blood and is described herein with reference to that use but it should be understood that the invention is applicable to other analytic determinations.
Electrochemical biosensors generally comprise a cell having a working electrode, a counter electrode and a reference electrode. Sometimes the function of the counter and reference electrodes are combined in a single electrode called a “counter/reference” electrode or “pseudo reference electrode”. As herein used the term “counter electrode” includes a counter/reference electrode where the context so admits.
The sample containing the analyte is brought into contact with a reagent containing an enzyme and a redox mediator in the cell. Either the mediator is reduced (receives at least one electron) while the analyte is oxidised (donates at least one electron) or visa versa. Usually it is the analyte which is oxidised and the mediator which is reduced. The invention will be herein described principally with reference to that system but it is also applicable to systems in which the analyte is reduced and the mediator oxidised.
Electrochemical glucose analysers such as those used by diabetics to monitor blood glucose levels or such as are used in clinics and hospitals are commonly based upon the use of an enzyme such as glucose oxidase dehydrogenase (GOD) and a redox mediator such as a ferricyanide or ferrocyanide. In such prior art system, the sample (e.g. blood) containing the analyte (e.g. glucose) is brought into contact with the reagents in the cell. Glucose is oxidised to: gluconic acid and the glucose oxidase is thereby reduced. The mediator then re-oxidizes the glucose oxidase and is reduced in the process. The reduced mediator is then re-oxidized when it transfers electrons to the working electrode. After allowing passage of a predetermined time, sufficient to obtain an accurate estimate of the Faraday current, the concentration of glucose is estimated from the magnitude of the current or voltage signal then measured.
Prior art electrochemical cells consist of two (or three) adjacent electrodes spaced apart on one side of an insulator and adapted for connection to a measuring device. A target area on which the blood sample is placed is defined on or between the electrodes. Co-pending Application PCT/AU95/00207 describes a cell in which electrodes are disposed on opposite sides of a porous membrane, one of the electrodes having a liquid permeable target area.
In the prior art there is a need to separate the working electrode from the counter (or counter/reference) electrode by a sufficient distance to avoid products of electrochemical reaction at one electrode from interfering with those at the other. In practice a separation of the electrodes of more than 500 μm is required to achieve acceptable accuracy.
Each batch of cells is required to have been previously calibrated and leads to inaccuracies during use because of variations within the batch, in sample composition, and in ambient conditions.
It is desired to improve the accuracy and reliability of such biosensors. Achievement of these objectives is made difficult in the case of sensors intended to determine the concentration of analytes in blood because blood contains dissolved gases, ions, colloids, complex micelles, small scale cellular debris, and living cellular components in a predominantly aqueous medium. Any of these may interfere in the determination. Existing sensors are also susceptible to influence from other interfering substances that may be present in the sample and which may be oxidised at the working electrode and mistakenly identified as the analyte of interest. Alternatively, the interfering substances may reduce the oxidised form of the redox mediator. These effects will give artificially elevated estimates of the analyte concentration. Additionally there is always some reduced redox mediator present before the analyte is added and its concentration needs to be known and subtracted from the measured value of reduced mediator to give an accurate concentration of the analyte. Moreover, oxygen in the blood may act as a redox mediator for glucose oxidase dehydrogenase (GOD) in competition with ferrocyanide. Thus high oxygen concentrations can lead to low stimates of glucose concentration. In addition the measurements are sensitive to factors such as changes in humidity, temperature, solution viscosity and haematocrit content.
It is an object of the present invention to provide a method of analysis and apparatus for use in the method which avoid or ameliorate at least some of the disadvantages of the prior art It is an object of preferred forms of the invention to provide a biosensor of improved accuracy, and/or reliability and/or speed and a method for its use.
According to one aspect the invention consists in a method for determining the concentration of a reduced (or oxidised) form of a redox species in an electrochemical cell of the kind comprising a working electrode and a counter electrode spaced from the working electrode by a predetermined distance, said method comprising the steps of:
The concentration measured in this way is substantially independent of variation if any in the diffusion coefficient of the reduced form and therefore is compensated for variations in temperature and viscosity. The concentration so measured is independent of variations in haematocit and other substances which affect the diffusion coefficient of the reduced form of the redox species.
It will be appreciated that the method of the invention is equally applicable for determining the concentration of a reduced form of a redox species or an oxidized form of a redox species in the cell. In the case that the concentration of the reduced form is to be determined the potential of the working electrode must be maintained such that the rate of electro oxidation of the reduced form is diffusion controlled in step (2) and it is the concentration of the reduced form that is obtained in step (5). In the case that the concentration of oxidized form is to be determined, the potential of the working electrode must be maintained such that the rate of electro reduction of the oxidized form is diffusion controlled in step (2) and it is the concentration of the oxidized form that is obtained in step (5).
The redox species may be an analyte or may be a redox mediator.
In preferred embodiments of the method a mediator is used and the concentration of the reduced (or oxidized) form of the mediator is in turn indicative of the concentration of an analyte and a measure of the diffusion coefficient of the reduced (or oxidized) form of the mediator is determined as a precursor to the determination of the concentration of the analyte.
For preference the cell comprises a working electrode and counter/reference electrode. If a reference electrode separate from a counter electrode is used, then the reference electrode may be in any convenient location in which it is in contact with the sample in the sensor.
In contrast to prior art when conducting the method of the invention, the electrodes are sufficiently close that the products of electrochemical reaction at the counter electrode migrate to the working electrode during the period of the test. For example, in an enzyme ferricyanide system, the ferrocyanide produced at the counter electrode diffuses to the working electrode.
This allows a steady state concentration profile to be achieved between the electrodes leading to a steady state current. This in turn allows the diffusion coefficient and concentration of the redox species (mediator) to be measured independently of sample variations and therefore greatly improves accuracy and reliability.
The method also permits the haematocrit concentration of blood to be determined from the diffusion coefficient by use of look-up tables (or by separation of red cells from plasma and measurement of the diffusion coefficient of the red cell fraction) and the plasma fraction, and comparing the two.
According to a second aspect, the invention consists in apparatus for determining the concentration of a redox species in an electrochemical cell comprising:
In preferred embodiments the cell has an effective volume of 1.5 microlitres or less. Apparatus for use in the invention may comprise a porous membrane, a working electrode on one side of the membrane, a counter/reference electrode on the other side, said electrodes together with a zone of the membrane therbetween defining an electrochemical cell, and wherein the membrane extends laterally from the cell to a sample deposition area spaced apart from the cell zone by a distance greater than the thickness of the membrane.
Preferably the porous membrane, the distance of the target area from the cell portion, and the membrane thickness are so selected in combination that when blood (comprising plasma and red cells) is placed on the target area a plasma front diffuses laterally towards the electrochemical cell zone in advance of the red cells.
It is thus possible to fill a thin layer electrochemical cell with plasma substantially free of haematocrit which would cause a variation in the diffusion coefficient of the redox mediator and which would affect the accuracy of the test as hereinafter explained.
In preferred embodiments of the biosensor according to the invention a second electrochemical cell zone of the membrane is defined by a second working electrode and a second counter/reference electrode on the opposite side of the membrane from the second working electrode. The second electrochemical cell zone is situated intermediate the first cell zone and the sample deposition or “target” area, or is situated on the side of the target area remote from the first electrochemical zone. In these embodiments the plasma comes into contact with enzyme in, or on route to, the first electrochemical cell while plasma reaching the second cell does not. The first cell thus in use measures the concentration of reduced mediator in the presence of plasma (including electrochemically interfering substances), and enzyme while the second electrochemical cell measures it in the presence of plasma (including electrochemically interfering substances) and in the absence of enzyme. This allows determination of the concentration of the reduced interfering substances in the second cell and the concentration of reduced interfering substances plus analyte in the first cell. Subtraction of the one value from the other gives the absolute concentration of analyte.
In a highly preferred embodiment of the invention a hollow cell is employed wherein the working and reference (or counter/reference) electrodes are spaced apart by less than 500 μm and preferably by from 20-200 μm.
The invention will now be more particularly described by way of example only with reference to the accompanying drawings wherein:
In FIGS. 5 to 12, components corresponding in function to components of the embodiment of FIGS. 1 to 4 are identified by identical numerals or indicia.
With reference to FIGS. 1 to 4 there is shown a first embodiment of apparatus of the invention, in this case a biosensor for determining glucose in blood. The embodiment comprises a thin strip membrane 1 having upper and lower surfaces 2, 3 and having a cell zone 4 defined between a working electrode 5 disposed on upper surface 2 and a counter electrode 6 disposed on lower surface 3. The membrane thickness is selected so that the electrodes are separated by a distance “1” which is sufficiently close that the products of electrochemical reaction at the counter electrode migrate to the working electrode during the time of the test and a steady state diffusion profile is substantially achieved. Typically, “1” will be less than 500 μm. A sample deposition or “target” area 7 defined on upper surface 2 of membrane 1 is spaced at a distance greater than the membrane thickness from cell zone 4. Membrane 1 has a diffusion zone 8 extending between target area 7 and cell zone 4. A suitable reagent including a redox mediator “M”, an enzyme “E” and a pH buffer “B” are contained within cell zone 4 of the membrane and/or between cell zone 4 and target area 7. The reagent may also include stabilisers and the like.
In some cases it is preferable to locate the enzyme and mediator and/or the buffer in different zones of the membrane. For example the mediator may be initially located within electrochemical cell zone 4 while the enzyme may be situated below target area 7 or in diffusion zone 8.
Hemoglobin releases oxygen at low pH's, but at higher pH's it binds oxygen very firmly. Oxygen acts as a redox mediator for glucose oxidase dehydrogenase (GOD). In a glucose sensor this competes with the redox mediator leading to low estimates of glucose concentration. Therefore if desired a first pH buffer can be contained in the vicinity of target area 7 to raise the pH to such a level that all the oxygen is bound to hemoglobin. Such a pH would be non-optimal for GOD/glucose kinetics and would consequently be detrimental to the speed and sensitivity of the test. In a preferred embodiment of the invention a second pH buffer is contained as a reagent in the vicinity of the working electrode to restore the pH to kinetically optimal levels. The use of a second buffer does not cause oxygen to be released from the hemoglobin as the hemoglobin is contained within the blood cells which are retained near blood target area 7 or are retarded in diffusion in comparison with the plasma and therefore not influenced by the second buffer. In this manner oxygen interference may be greatly reduced or eliminated.
In use of the sensor a drop of blood containing a concentration of glucose to be determined is placed on target zone 7. The blood components wick towards cell zone 4, the plasma component diffusing more rapidly than red blood cells so that a plasma front reaches cell zone 4 in advance of blood cells.
When the plasma wicks into contact with the reagent, the reagent is dissolved and a reaction occurs that oxidises the analyte and reduces the mediator. After allowing a predetermined time to complete this reaction an electric potential difference is applied between the working electrode and the counter electrode. The potential of the working electrode is kept sufficiently anodic such that the rate of electro oxidation of the reduced form of the mediator at the working electrode is determined by the rate of diffusion of the reduced form of the mediator to the working electrode, and not by the rate of electron transfer across the electrode/solution interface.
In addition the concentration of the oxidised form of the mediator at the counter electrode is maintained at a level sufficient to ensure that when a current flows in the electrochemical cell the potential of the counter electrode, and thus also the potential of the working electrode, is not shifted so far in the cathodic direction that the potential of the working electrode is no longer in the diffusion controlled region. That is to say, the concentration of the oxidized form at the counter electrode must be sufficient to maintain diffusion controlled electro oxidation of the reduced form of the mediator at the working electrode.
The behavior of a thin layer cell is such that if both oxidised and reduced forms of the redox couple are present, eventually a steady state concentration profile is established across the cell. This results in a steady state current. It has been found that by comparing a measure of the steady state current with the rate at which the current varies in the current transient before the steady state is achieved, the diffusion coefficient of the redox mediator can be measured as well as its concentration. This is in contrast to the Cottrell current that is measured in the prior art. By measuring the Cottrell current at known times after application of a potential to the sensor electrodes it is only possible to determine the product concentration times square root of the diffusion coefficient and therefore it is not possible to determine the concentration of the mediator independent of its diffusion coefficient.
In a cell according to the current invention, by solving the appropriate diffusion equations it can be shown that over a restricted time range a plot of ln(i/i∞−1) vs time (measured in seconds) is linear and has a slope (denoted by S) which is equal to −4π2D/12, where “i” is the current at time “t”, “i∞” is the steady state current, “D” is the diffusion coefficient in cm2/sec, “l” is the distance between the electrodes in cm and “π” is approximately 3.14159. The concentration of reduced mediator present when the potential was applied between the electrodes is given by 2π2i∞/FAIS, where “F” is Faraday's constant, A is the working electrode area and the other symbols are as given above. As this later formula uses S it includes the measured value of the diffusion coefficient.
Since l is a constant for a given cell, measurement of i as a function of time and i∞ enable the value of the diffusion coefficient of the redox mediator to be calculated and the concentration of the analyte to be determined.
Moreover the determination of analyte concentration compensates for any variation to the diffusion coefficient of the species which is electro oxidised or electro reduced at the working electrode. Changes in the value of the diffusion coefficient may occur as a result of changes in the temperature and viscosity of the solution or variati n of the membrane permeability. Other adjustments to the measured value of the concentration may be necessary to account for other factors such as changes to the cell geometry, changes to the enzyme chemistry or other factors which may effect the measured concentration. If the measurement is made on plasma substantially free of haematocrit (which if present causes variation in the diffusion coefficient of the redox mediator) the accuracy of the method is further improved.
Each of electrodes 5, 6 has a predefined area In the embodiments of FIGS. 1 to 4 cell zone 4 is defined by edges 9, 10, 11 of the membrane which correspond with edges of electrodes 5, 6 and by leading (with respect to target area 7) edges 12, 13 of the electrodes. In the present example the electrodes are about 600 angstrom thick and are from 1 to 5 mm wide.
Optionally, both sides of the membrane are covered with the exception of the target area 7 by laminating layers 14 (omitted from plan views) which serves to prevent evaporation of water from the sample and to provide mechanical robustness to the apparatus. Evaporation of water is undesirable as it concentrates the sample, allows the electrodes to dry out, and allows the solution to cool, affecting the diffusion coefficient and slowing the enzyme kinetics, although diffusion coefficient can be estimated as above.
A second embodiment according to the invention, shown in
The same benefit is achieved by a different geometry in the embodiment of
Although the embodiments of FIGS. 1 to 8 are unitary sensors, it will be understood that a plurality of sensors may be formed on a single membrane as shown in the embodiment of FIGS. 9 to 11. In this case the electrodes of one sensor are conductively connected to those of an adjacent sensor. Sensors may be used successively and severed from the strip after use.
In the embodiment of FIGS. 9 to 11 electrode dimensions are defined in the diffusion direction (indicated by arrow) by the width of the electrode in that direction. The effective dimension of the electrode in a direction transverse to diffusion direction is defined between compressed volumes 16 of the membrane in a manner more fully described in co-pending Application PCT/AU96/00210, the disclosure of which is incorporated herein by reference in its entirety. For clarity optional laminated layer 14 of
In the embodiment of
It will be understood that the method of the invention may be performed with a cell constructed in accord with co-pending application PCT/AU95/00207 or cells of other known design provided these are modified to provide a sufficiently small distance between electrode faces.
The method of the invention will now be further exemplified with reference to
A membrane 130 microns thick was coated on both sides with a layer of Platinum 60 nanometers thick. An area of 12.6 sq. mm was defined by compressing the membrane. 1.5 microlitres of a solution containing 0.2 Molar potassium ferricyanide and 1% by weight glucose oxidase dehydrogenase was added to the defined area of the membrane and the water allowed to evaporate.
The platinum layers were then connected to a potentiostat to be used as the working and counter/reference electrodes. 3.0 microlitres of an aqueous solution containing 5 millimolar D-glucose and 0.9 wt % NaCl was dropped on to the defined area of the membrane. After an elapse of 20 seconds a voltage of 300 millivolts was applied between the working and counter/reference electrodes and the current recorded for a further 30 seconds at intervals of 0.1 seconds.
The steady state current is one in which no further significant current change occ during the test As will be understood by those skilled in the art, a minimum current may be reached after which there may be a drift due to factors such as latral diffusion, evaporation, interfering electrochemical rections or the like. However, in practice it is not difficult to estimate the “steady state” current (i∞). One method for doing so involves approximating an initial value for i∞. Using the fit of the i versus t data to the theoretical curve a better estimate of i∞ is then obtained. This is repeated reitrantively until the measured value and approximated value converge to within an acceptable difference, thus yielding an estimated i∞.
In practice, the measurements of current i at time t are made between a minimum time t min and a maximum time t max after the potential is applied. The minimum and maximum time are determined by the applicability of the equations and can readily be determined by experiment of a routine nature. If desired the test may be repeated by switching off the voltage and allowing the concentration profiles of the redox species to return towards their initial states.
It is to be understood that the analysis of the current v. time curve to obtain values of the Diffusion Co-efficient and/or concentration is not limited to the method given above but could also be achieved by other methods.
For instance, the early part of the current v time curve could be analysed by the Cottrell equation to obtain a value of D1/2×Co(Co=Concentration of analyte) and the steady state current analysed to obtain a value of D×Co. These 2 values can then be compared to obtain D and C separately.
It will be understood that in practice of the invention an electrical signal is issued by the apparatus which is indicative of change in current with time. The signal may be an analogue or digital signal or may be a series of signals issued at predetermined time intervals. These signals may be processed by means of a microprocessor or other conventional circuit to perform the required calculations in accordance with stored algorithms to yield an output signal indicative of the diffusion coefficient, analyte concentration, haematocrit concentration or the like respectively. One or more such output signals may be displayed by means of an analogue or digital display.
It is also possible by suitable cell design to operate the cell as a depletion cell measuring the current required to deplete the mediator. For example in the embodiment of
The depletion measurement may be made prior to, during or subsequent to, the measurement of diffusion coefficient by the method of the invention. This enables a substantial improvement in accuracy and reproducibility to be obtained.
In the embodiments described the membrane is preferably an asymmetric porous membrane of the kind described in U.S. Pat. No. 4,629,563 and U.S. Pat. No. 4,774,039 both of which are incorporated herein in their entirety by reference. However symmetrical porous membranes may be employed. The membrane may be in the form of a sheet, tube, hollow fibre or other suitable form.
If the membrane is asymmetric the target area is preferably on the more open side of the asymetric membrane. The uncompressed membrane desirably has a thickness of from 20 to 500 μm. The minimum thickness is selected having regard to speed, sensitivity, accuracy and cost. If desired a gel may be employed to separate haematocrit from GOD. The gel may be present between the electrodes and/or in the space between the sample application area and the electrodes.
The working electrode is of any suitable metal for example gold, silver, platinum, palladium, iridium, lead, a suitable alloy. The working electrode may be preformed or formed in situ by any suitable method for example sputtering, evaporation under partial vacuum, by electrodeless plating, electroplating, or the like. Suitable non-metal conductors may also be used for electrode construction. For example, conducting polymers such as poly(pyrrole), poly(aniline), porphyrin “wires”, poly(isoprene) and poly (cis-butadiene) doped with iodine and “ladder polymers”. Other non-metal electrodes may be graphite or carbon mixed with a binder, or a carbon filled plastic. Inorganic electrodes such as In2O3 or SnO2 may also be used. The counter/reference electrode may for example be of similar construction to the working electrode. Nickel hydroxide or a silver halide may also be used to form the counter/reference electrode. Silver chloride may be employed but it will be understood that chloridisation may not be necessary and silver may be used if sufficient chloride ions are present in the blood sample. Although in the embodiments described the working electrode is shown on the upper surface of the biosensor and the counter/reference electrode is on the lower surface, these may be reversed.
It is preferable that the working electrode and counter (or countert/reference) electrodes are of substantially the same effective geometric area If a separate reference and counter electrode are employed, they may be of similar construction. The reference electrode can be in any suitable location.
It will be understood that the features of one embodiment herein described may be combined with those of another. The invention is not limited to use with any particular combination of enzyme and mediator and combinations such as are described in EP 0351892 or elsewhere may be employed. The system may be used to determine analytes other than glucose (for example, cholesterol) by suitable adaptation of reagents and by appropriate membrane selection. The system may also be adapted for use with media other than blood. For example the method may be employed to determine the concentration of contaminants such as chlorine, iron, lead, cadmium, copper, etc., in water.
Although the cells herein described have generally planar and parallel electrodes it will be understood that other configurations may be employed, for example one electrode could be a rod or needle and the other a concentric sleeve.
It will be apparent to those skilled in the art from the disclosure hereof the invention may be embodied in other forms without departing from the inventive concept herein disclosed.
|Brevet cité||Date de dépôt||Date de publication||Déposant||Titre|
|US4053381 *||19 mai 1976||11 oct. 1977||Eastman Kodak Company||Device for determining ionic activity of components of liquid drops|
|US4076596 *||7 oct. 1976||28 févr. 1978||Leeds & Northrup Company||Apparatus for electrolytically determining a species in a fluid and method of use|
|US4088448 *||16 sept. 1976||9 mai 1978||Lilja Jan Evert||Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses|
|US4224125 *||26 sept. 1978||23 sept. 1980||Matsushita Electric Industrial Co., Ltd.||Enzyme electrode|
|US4233029 *||25 oct. 1978||11 nov. 1980||Eastman Kodak Company||Liquid transport device and method|
|US4254083 *||23 juil. 1979||3 mars 1981||Eastman Kodak Company||Structural configuration for transport of a liquid drop through an ingress aperture|
|US4254546 *||11 sept. 1978||10 mars 1981||Ses, Incorporated||Photovoltaic cell array|
|US4259165 *||10 déc. 1979||31 mars 1981||Hokushin Electric Works, Ltd.||Dissolved oxygen probe|
|US4301412 *||29 oct. 1979||17 nov. 1981||United States Surgical Corporation||Liquid conductivity measuring system and sample cards therefor|
|US4301414 *||29 oct. 1979||17 nov. 1981||United States Surgical Corporation||Disposable sample card and method of making same|
|US4303887 *||29 oct. 1979||1 déc. 1981||United States Surgical Corporation||Electrical liquid conductivity measuring system|
|US4307186 *||30 juil. 1980||22 déc. 1981||Agfa-Gevaert Aktiengesellschaft||Photographic emulsion with stabilizer process for its preparation, photographic materials and process for the production of photographic images|
|US4319969 *||14 août 1980||16 mars 1982||Asahi Glass Company, Ltd.||Aqueous alkali metal chloride electrolytic cell|
|US4374013 *||3 mars 1981||15 févr. 1983||Enfors Sven Olof||Oxygen stabilized enzyme electrode|
|US4404066 *||13 mai 1982||13 sept. 1983||The Yellow Springs Instrument Company||Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme|
|US4431004 *||27 oct. 1981||14 févr. 1984||Bessman Samuel P||Implantable glucose sensor|
|US4431507 *||12 janv. 1982||14 févr. 1984||Matsushita Electric Industrial Co., Ltd.||Enzyme electrode|
|US4508613 *||19 déc. 1983||2 avr. 1985||Gould Inc.||Miniaturized potassium ion sensor|
|US4517287 *||25 mars 1980||14 mai 1985||Boehringer Mannheim Gmbh||Method and reagent for the enzymatic determination of enzyme substrates|
|US4517291 *||15 août 1983||14 mai 1985||E. I. Du Pont De Nemours And Company||Biological detection process using polymer-coated electrodes|
|US4533440 *||4 août 1983||6 août 1985||General Electric Company||Method for continuous measurement of the sulfite/sulfate ratio|
|US4545382 *||22 oct. 1982||8 oct. 1985||Genetics International, Inc.||Sensor for components of a liquid mixture|
|US4552840 *||2 déc. 1982||12 nov. 1985||California And Hawaiian Sugar Company||Enzyme electrode and method for dextran analysis|
|US4554064 *||28 mars 1984||19 nov. 1985||Imasco-Cdc Research Foundation||Dual working-electrode electrochemical detector for high performance liquid chromatography|
|US4591550 *||5 avr. 1984||27 mai 1986||Molecular Devices Corporation||Device having photoresponsive electrode for determining analytes including ligands and antibodies|
|US4629563 *||11 août 1981||16 déc. 1986||Brunswick Corporation||Asymmetric membranes|
|US4654197 *||12 oct. 1984||31 mars 1987||Aktiebolaget Leo||Cuvette for sampling and analysis|
|US4664119 *||4 déc. 1985||12 mai 1987||University Of Southern California||Transcutaneous galvanic electrode oxygen sensor|
|US4711245 *||7 mai 1984||8 déc. 1987||Genetics International, Inc.||Sensor for components of a liquid mixture|
|US4774039 *||19 nov. 1986||27 sept. 1988||Brunswick Corporation||Dispersing casting of integral skinned highly asymmetric polymer membranes|
|US4782265 *||22 janv. 1985||1 nov. 1988||U.S. Philips Corporation||Electrochemical luminescent cell|
|US4790925 *||18 sept. 1987||13 déc. 1988||Mine Safety Appliances Company||Electrochemical gas sensor|
|US4897173 *||19 juin 1986||30 janv. 1990||Matsushita Electric Industrial Co., Ltd.||Biosensor and method for making the same|
|US4900424 *||30 nov. 1987||13 févr. 1990||Unilever Patent Holdings B.V.||Electrochemical measurement cell|
|US4911794 *||18 juin 1987||27 mars 1990||Molecular Devices Corporation||Measuring with zero volume cell|
|US4919770 *||19 déc. 1986||24 avr. 1990||Siemens Aktiengesellschaft||Method for determining the concentration of electro-chemically convertible substances|
|US4963815 *||10 juil. 1987||16 oct. 1990||Molecular Devices Corporation||Photoresponsive electrode for determination of redox potential|
|US4988429 *||22 juin 1990||29 janv. 1991||Dragerwerk Aktiengesellschaft||Measuring cell for an electrochemical gas sensor|
|US4989452 *||23 juin 1989||5 févr. 1991||Solinst Canada Ltd.||Liquid-level detector|
|US5059908 *||31 mai 1990||22 oct. 1991||Capital Controls Company, Inc.||Amperimetric measurement with cell electrode deplating|
|US5064516 *||27 juin 1988||12 nov. 1991||Gas Research Institute||Measuring gas levels|
|US5089112 *||11 janv. 1990||18 févr. 1992||Associated Universities, Inc.||Electrochemical biosensor based on immobilized enzymes and redox polymers|
|US5108564 *||15 août 1991||28 avr. 1992||Tall Oak Ventures||Method and apparatus for amperometric diagnostic analysis|
|US5120420 *||31 mars 1989||9 juin 1992||Matsushita Electric Industrial Co., Ltd.||Biosensor and a process for preparation thereof|
|US5122244 *||4 févr. 1991||16 juin 1992||Boehringer Mannheim Gmbh||Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor|
|US5126034 *||21 juil. 1989||30 juin 1992||Medisense, Inc.||Bioelectrochemical electrodes|
|US5128015 *||13 mars 1989||7 juil. 1992||Tall Oak Ventures||Method and apparatus for amperometric diagnostic analysis|
|US5141868 *||27 nov. 1989||25 août 1992||Internationale Octrooi Maatschappij "Octropa" Bv||Device for use in chemical test procedures|
|US5151168 *||24 sept. 1990||29 sept. 1992||Micron Technology, Inc.||Process for metallizing integrated circuits with electrolytically-deposited copper|
|US5156972 *||5 sept. 1990||20 oct. 1992||The State Of Israel, Atomic Energy Commission, Soreq Nuclear Research Center||Analyte specific chemical sensor with a ligand and an analogue bound on the sensing surface|
|US5171689 *||18 avr. 1989||15 déc. 1992||Matsushita Electric Industrial Co., Ltd.||Solid state bio-sensor|
|US5192415 *||2 mars 1992||9 mars 1993||Matsushita Electric Industrial Co., Ltd.||Biosensor utilizing enzyme and a method for producing the same|
|US5229282 *||26 nov. 1990||20 juil. 1993||Matsushita Electric Industrial Co., Ltd.||Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system|
|US5243516 *||15 déc. 1989||7 sept. 1993||Boehringer Mannheim Corporation||Biosensing instrument and method|
|US5243526 *||7 mai 1991||7 sept. 1993||Mitsubishi Jidosha Kogyo Kabushiki Kaisha||Output control apparatus for vehicle|
|US5269903 *||22 oct. 1991||14 déc. 1993||Yoshito Ikariyama||Microbioelectrode and method of fabricating the same|
|US5272087 *||19 avr. 1989||21 déc. 1993||Centre National De La Recherche Scientifique (C.N.R.S.)||Enzymatic electrode and its preparation method|
|US5282950 *||14 juil. 1992||1 févr. 1994||Boehringer Mannheim Gmbh||Electrochemical analysis system|
|US5312590 *||24 avr. 1989||17 mai 1994||National University Of Singapore||Amperometric sensor for single and multicomponent analysis|
|US5314605 *||25 nov. 1992||24 mai 1994||Dragerwerk Aktiengesellschaft||Measuring cell for electrochemically detecting a gas|
|US5320732 *||11 juin 1993||14 juin 1994||Matsushita Electric Industrial Co., Ltd.||Biosensor and measuring apparatus using the same|
|US5364028 *||3 mars 1994||15 nov. 1994||Wozniak Walter E||Pneumatic timed spray dispenser|
|US5366609 *||8 juin 1993||22 nov. 1994||Boehringer Mannheim Corporation||Biosensing meter with pluggable memory key|
|US5382346 *||20 oct. 1993||17 janv. 1995||Kyoto Daiichi Kagaku Co., Ltd.||Biosensor and method of quantitative analysis using the same|
|US5385846 *||3 juin 1993||31 janv. 1995||Boehringer Mannheim Corporation||Biosensor and method for hematocrit determination|
|US5388163 *||23 déc. 1991||7 févr. 1995||At&T Corp.||Electret transducer array and fabrication technique|
|US5393399 *||7 sept. 1993||28 févr. 1995||Gie Cylergie||Amperometric measuring device having an electrochemical sensor|
|US5395504 *||1 févr. 1994||7 mars 1995||Asulab S.A.||Electrochemical measuring system with multizone sensors|
|US5399256 *||7 janv. 1994||21 mars 1995||Bioanalytical Systems, Inc.||Electrochemical detector cell|
|US5413690 *||23 juil. 1993||9 mai 1995||Boehringer Mannheim Corporation||Potentiometric biosensor and the method of its use|
|US5437999 *||22 févr. 1994||1 août 1995||Boehringer Mannheim Corporation||Electrochemical sensor|
|US5443710 *||18 nov. 1992||22 août 1995||Research Foundation, The City University Of New York||Microelectrodes and their use in a cathodic electrochemical current arrangement with telemetric application|
|US5496453 *||12 oct. 1994||5 mars 1996||Kyoto Daiichi Kagaku Co., Ltd.||Biosensor and method of quantitative analysis using the same|
|US5508171 *||21 févr. 1994||16 avr. 1996||Boehringer Mannheim Corporation||Assay method with enzyme electrode system|
|US5509410 *||27 juil. 1994||23 avr. 1996||Medisense, Inc.||Strip electrode including screen printing of a single layer|
|US5512159 *||19 août 1994||30 avr. 1996||Matsushita Electric Industrial Co. Ltd.||Biosensor|
|US5517313 *||21 févr. 1995||14 mai 1996||Colvin, Jr.; Arthur E.||Fluorescent optical sensor|
|US5520787 *||3 mars 1995||28 mai 1996||Abbott Laboratories||Diagnostic flow cell device|
|US5527446 *||13 avr. 1995||18 juin 1996||United States Of America As Represented By The Secretary Of The Air Force||Gas sensor|
|US5567302 *||7 juin 1995||22 oct. 1996||Molecular Devices Corporation||Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change|
|US5575895 *||30 mai 1995||19 nov. 1996||Matsushita Electric Industrial Co., Ltd.||Biosensor and method for producing the same|
|US5611908 *||21 déc. 1995||18 mars 1997||Dr agerwerk Aktiengesellschaft||Method of operating and amperometric measuring cell|
|US5620579 *||5 mai 1995||15 avr. 1997||Bayer Corporation||Apparatus for reduction of bias in amperometric sensors|
|US5645709 *||7 déc. 1994||8 juil. 1997||Van Den Bergh Foods Co., Division Of Conopco, Inc.||Methods and apparatus for electrochemical measurements|
|US5682884 *||27 juil. 1994||4 nov. 1997||Medisense, Inc.||Strip electrode with screen printing|
|US5726585 *||24 mai 1996||10 mars 1998||Samsung Electronics Co., Ltd.||Switching circuit for use in a semiconductor memory device|
|US5727548 *||6 juin 1995||17 mars 1998||Medisense, Inc.||Strip electrode with screen printing|
|US5762770 *||30 juin 1995||9 juin 1998||Boehringer Mannheim Corporation||Electrochemical biosensor test strip|
|US5828890 *||30 janv. 1997||27 oct. 1998||Northbrook Services||System for interrupting program operation when an out-of-range value is encountered to correct a data value|
|US5849174 *||1 août 1995||15 déc. 1998||Medisense, Inc.||Electrodes and their use in analysis|
|US5909114 *||23 oct. 1997||1 juin 1999||Nakano Vinegar Co., Ltd.||Coulometric analysis method and a device therefor|
|US5942102 *||7 mai 1997||24 août 1999||Usf Filtration And Separations Group Inc.||Electrochemical method|
|US6153069 *||9 févr. 1995||28 nov. 2000||Tall Oak Ventures||Apparatus for amperometric Diagnostic analysis|
|US6193873 *||15 juin 1999||27 févr. 2001||Lifescan, Inc.||Sample detection to initiate timing of an electrochemical assay|
|US6251260 *||24 août 1998||26 juin 2001||Therasense, Inc.||Potentiometric sensors for analytic determination|
|US6284125 *||19 juin 1996||4 sept. 2001||Usf Filtration And Separations Group, Inc.||Electrochemical cell|
|US6413410 *||18 juil. 2000||2 juil. 2002||Lifescan, Inc.||Electrochemical cell|
|US6544212 *||31 juil. 2001||8 avr. 2003||Roche Diagnostics Corporation||Diabetes management system|
|US6780756 *||28 févr. 2003||24 août 2004||Texas Instruments Incorporated||Etch back of interconnect dielectrics|
|Brevet citant||Date de dépôt||Date de publication||Déposant||Titre|
|US7146203 *||16 déc. 2004||5 déc. 2006||Elliot Botvinick||Implantable biosensor and methods of use thereof|
|US7648468||31 déc. 2002||19 janv. 2010||Pelikon Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7666149||28 oct. 2002||23 févr. 2010||Peliken Technologies, Inc.||Cassette of lancet cartridges for sampling blood|
|US7674232||31 déc. 2002||9 mars 2010||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7682318||12 juin 2002||23 mars 2010||Pelikan Technologies, Inc.||Blood sampling apparatus and method|
|US7699791||12 juin 2002||20 avr. 2010||Pelikan Technologies, Inc.||Method and apparatus for improving success rate of blood yield from a fingerstick|
|US7713214||18 déc. 2002||11 mai 2010||Pelikan Technologies, Inc.||Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing|
|US7717863||31 déc. 2002||18 mai 2010||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7731729||13 févr. 2007||8 juin 2010||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7822454||3 janv. 2005||26 oct. 2010||Pelikan Technologies, Inc.||Fluid sampling device with improved analyte detecting member configuration|
|US7833171||13 févr. 2007||16 nov. 2010||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7841992||22 déc. 2005||30 nov. 2010||Pelikan Technologies, Inc.||Tissue penetration device|
|US7850621||7 juin 2004||14 déc. 2010||Pelikan Technologies, Inc.||Method and apparatus for body fluid sampling and analyte sensing|
|US7850622||22 déc. 2005||14 déc. 2010||Pelikan Technologies, Inc.||Tissue penetration device|
|US7862520||20 juin 2008||4 janv. 2011||Pelikan Technologies, Inc.||Body fluid sampling module with a continuous compression tissue interface surface|
|US7874994||16 oct. 2006||25 janv. 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7892183||3 juil. 2003||22 févr. 2011||Pelikan Technologies, Inc.||Method and apparatus for body fluid sampling and analyte sensing|
|US7901362||31 déc. 2002||8 mars 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7909774||13 févr. 2007||22 mars 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7909775||26 juin 2007||22 mars 2011||Pelikan Technologies, Inc.||Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge|
|US7909777||29 sept. 2006||22 mars 2011||Pelikan Technologies, Inc||Method and apparatus for penetrating tissue|
|US7909778||20 avr. 2007||22 mars 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7914465||8 févr. 2007||29 mars 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7938787||29 sept. 2006||10 mai 2011||Pelikan Technologies, Inc.||Method and apparatus for penetrating tissue|
|US7988644||2 août 2011||Pelikan Technologies, Inc.||Method and apparatus for a multi-use body fluid sampling device with sterility barrier release|
|US8543182||29 juin 2006||24 sept. 2013||Metronom Health, Inc.||Implantable biosensor and methods of use thereof|
|US9072842||31 juil. 2013||7 juil. 2015||Sanofi-Aventis Deutschland Gmbh||Method and apparatus for penetrating tissue|
|US9089294||16 janv. 2014||28 juil. 2015||Sanofi-Aventis Deutschland Gmbh||Analyte measurement device with a single shot actuator|
|US9089678||21 mai 2012||28 juil. 2015||Sanofi-Aventis Deutschland Gmbh||Method and apparatus for penetrating tissue|
|US20050177035 *||16 déc. 2004||11 août 2005||Elliot Botvinick||Implantable biosensor and methods of use thereof|
|Classification aux États-Unis||204/403.01, 204/403.11|
|Classification internationale||G01N27/327, G01N27/49, C12Q1/00|
|Classification coopérative||Y10T29/49117, G01N27/3273, G01N27/3272, C12Q1/004, G01N27/403|
|Classification européenne||G01N27/404, G01N27/49, C12Q1/00B4|